Thu, April 6, 2023
Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023

Leland Gershell Downgraded (ASND) to Hold on, Apr 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ell-downgraded-asnd-to-hold-on-apr-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Downgraded "Ascendis Pharma A/S" (ASND) to Hold on, Apr 5th, 2023.

Leland has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 2 agree with Leland's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $108 on, Tuesday, April 4th, 2023
  • Tiago Fauth of "Credit Suisse" Downgraded from Buy to Hold on, Monday, April 3rd, 2023


These are the ratings of the 3 analyists that currently disagree with Leland


  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023

Publication Contributing Sources